This body of evidence makes it feasible to think that subjects with a low number of IL-2-producing CD4+ T cells in response to in vitro polyclonal stimuli display increased susceptibility to severe COVID-19 after SARS-CoV-2 infection. The gene discussed is CD4; the disease is COVID-19.